Valuation Becton, Dickinson and Company

Stocks

Market Closed - NYSE Other stock markets 16:00:02 2026-07-15 EDT			5-day change	1st Jan Change
154.88 ^USD	+2.81%		+2.87%	-20.19%

07-14	Goldman Sachs Adjusts Price Target on Becton, Dickinson and Company to $152 From $150, Maintains Neutral Rating	MT
07-14	Bactiguard lifted revenue but the operating loss widened	FW

Data adjusted to current consolidation scope

Fiscal Period: September	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	70,597	63,550	75,002	69,688	53,648	42,676	-	-
Change	-	-9.98%	18.02%	-7.08%	-23.02%	-20.45%	-	-
Enterprise Value (EV) ¹	85,924	78,609	89,465	88,081	72,188	58,619	56,710	55,152
Change	-	-8.51%	13.81%	-1.55%	-18.04%	-18.8%	-3.26%	-2.75%
P/E	35.9x	37.9x	52.3x	40.7x	32.2x	38.6x	29.8x	25.9x
PBR	2.95x	3.21x	3.71x	2.69x	2.1x	1.6x	1.57x	1.53x
PEG	-	-2.7x	-3.3x	2x	-17.36x	-1.2x	1x	1.7x
Capitalization / Revenue	3.49x	3.37x	3.87x	3.44x	2.46x	2.22x	2.17x	2.09x
EV / Revenue	4.24x	4.17x	4.62x	4.35x	3.31x	3.05x	2.88x	2.7x
EV / EBITDA	14.7x	15.2x	13.1x	12.4x	12x	10.5x	9.76x	9.1x
EV / EBIT	17.3x	18x	19.6x	18.3x	13.2x	12.2x	11.4x	10.5x
EV / FCF	25.2x	52.5x	42.3x	28.2x	27x	23.6x	18.2x	17.3x
FCF Yield	3.98%	1.91%	2.37%	3.54%	3.7%	4.23%	5.51%	5.79%
Dividend per Share ²	3.32	3.48	3.64	3.8	4.16	3.85	3.914	3.891
Rate of return	1.35%	1.56%	1.41%	1.58%	2.22%	2.49%	2.53%	2.51%
EPS ²	6.85	5.88	4.94	5.93	5.82	4.013	5.2	5.99
Distribution rate	48.5%	59.2%	73.7%	64.1%	71.5%	95.9%	75.3%	65%
Net sales ¹	20,248	18,870	19,372	20,245	21,840	19,203	19,702	20,439
EBITDA ¹	5,838	5,160	6,846	7,099	6,028	5,597	5,808	6,058
EBIT ¹	4,971	4,362	4,558	4,813	5,468	4,807	4,985	5,230
Net income ¹	2,002	1,689	1,424	1,726	1,678	1,125	1,449	1,680
Net Debt ¹	15,327	15,059	14,463	18,393	18,540	15,943	14,034	12,476
Reference price ²	245.82	222.83	258.53	241.10	187.17	154.88	154.88	154.88
Nbr of stocks (in thousands)	287,190	285,195	290,109	289,042	286,627	275,540	-	-
Announcement Date	11/4/21	11/10/22	11/9/23	11/7/24	11/6/25	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
BECTON, DICKINSON AND COMPANY	37.54x	2.99x	10.27x	2.56%	41.51B
ABBOTT LABORATORIES	22x	3.32x	12.36x	2.86%	155B
MEDTRONIC PLC	17.99x	3.16x	11.14x	3.74%	102B
CENCORA, INC.	16.81x	0.19x	11.89x	0.78%	58.81B
HOYA CORPORATION	32.32x	7.84x	20.51x	1.24%	52.82B
MEDLINE INC.	37.06x	1.36x	11.95x	0.21%	32.69B
DEXCOM, INC.	30.28x	5.4x	17.21x	-.--%	28.6B
WEST PHARMACEUTICAL SERVICES, INC.	42.5x	7.43x	26.82x	0.25%	25.27B
STERIS PLC	22.96x	3.36x	12.09x	1.26%	20.34B
SARTORIUS STEDIM BIOTECH	47.92x	6.43x	20.66x	0.45%	20.99B
Average	30.74x	4.15x	15.49x	1.34%	53.75B
Weighted average by Cap.	26.26x	3.67x	13.94x	2.03%